Urokinase receptor is a key player in tumour progression.
Taniguchi
T
T
Imperial Cancer Research Fund Molecular Oncology Unit, Imperial College School of Medicine, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
Lemoine
N R
NR
Kakkar
A K
AK
D002450:Cell Communication; D018450:Disease Progression; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000473:pathology*; D017395:Plasminogen Activator Inhibitor 1 / Q000502:physiology; D010960:Plasminogen Activators / Q000502:physiology*; D011956:Receptors, Cell Surface / Q000502:physiology*; D055293:Receptors, Urokinase Plasminogen Activator
D006133:Growth Substances; C524898:PLAUR protein, human; D017395:Plasminogen Activator Inhibitor 1; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D010960:Plasminogen Activators